European Companies Search Engine
Registration · Managing Director: Jochen Gann, Martin Schwarz · Authorized signatory (ppa) (4) · Address · Capital: €25,000 · Shareholder agreement · Proxy policy · Corporate Purpose · Subsidiary Hrb 10 Nov 2015 German Trade Register Announcements, Germany
Overview
Text
HRB 46440: Boehringer Ingelheim Invest GmbH, Ingelheim am
Unnamed street ??, 55216 Ingelheim a. Rhein, Germany
. GmbH. Partnership agreement of October 9, 2015. Business address:
Unnamed street ??, 55216 Ingelheim a. Rhein, Germany
. Subject: Acquisition and disposal, holding and management of shareholdings. The Company may also operate in the pharmaceutical business, in particular by developing, manufacturing and distributing chemical or pharmaceutical products itself or by entrusting others with them. The Company is authorised to acquire, lease, participate in similar or similar companies, assume their personal liability and representation, establish permanent establishments and branches at home and abroad, and operate all businesses likely to promote the Company's activities. Share capital: EUR 25,000.00. General representation scheme: If only one managing director is appointed, he shall represent the company alone. If several directors are appointed, the company is represented by two directors or by a managing director together with an authorized representative. Managing Director: Dr. Gann, Jochen, Bad Kreuznach, *??.??.????; Dr. Schwarz, Martin, Mainz, *??.??.????. Gesamtprokura together with a managing director or another authorized representative: Fidler, Malte, Frankfurt am Main, *??.??.????; ??????, ?????????, Hofheim am Taunus, *??.??.????; ????, ????????, Bretzenheim, *??.??.????; Grupp, Clemens, Mainz, *??.??.????.
This filing was translated from German to English. The filing refers to a past date, and does not necessarily reflect the current state. The latest known state is available on the following page: Boehringer Ingelheim Invest GmbH, Ingelheim a. Rhein, Germany.
